Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014

Size: px
Start display at page:

Download "Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014"

Transcription

1 MA PMP Pharmacy Data Entry and Data Submitter s FAQ Utilizing ASAP 4.2 Supplement to the MA PMP Pharmacy Data Entry and Data Submitter s Guide Utilizing ASAP 4.2 Massachusetts Department of Public Health (MDPH) Prescription Monitoring Program (MA PMP) and Drug Control Program (DCP) April 8, 2014 The MA PMP Pharmacy Data Entry and Data Submitter s FAQ Utilizing ASAP 4.2 (MA PMP Pharmacy FAQ) addresses questions regarding data submission to the Massachusetts Prescription Monitoring Program (MA PMP) as well as general MA PMP implementation issues. The MA PMP Pharmacy FAQ contain references to names and code values of fields from the Implementation Guide for the ASAP Standard for Prescription Monitoring Programs, Version 4 Release 2 (ASAP 4.2 Implementation Guide). Field names and code values are technical references for software providers. It is expected that data entry screens will often be customized to display more user-friendly terminology and choices for pharmacists and technicians. The software will, in many cases, translate the user-friendly codes to the ASAP values for submission to the MA PMP. Pharmacy personnel should consult with their software providers if they have questions about how field names or field codes are handled in their pharmacy software. 1 General implementation questions 1.1 Copies of Regulations Q) Is it possible to obtain an official copy of the 2010 amended regulations? A) To obtain official copies of the regulations, you can go to the Massachusetts State Bookstore on the web at: The MA PMP is authorized by M.G.L. Chapter 94C 24A. Implementing regulations for the DCP and the Massachusetts Board of Registration in Pharmacy (Board) are found at 105 CMR , 105 CMR , 247 CMR 2.00 and 247 CMR Guidance for pharmacies Q) Is there a website or update document that we can receive or access? A) The principal resources can be found by following the MA PMP link on the DCP website listed below. Updates will be available there for the MA PMP Pharmacy Data Entry and Data Submitter s Guide Utilizing ASAP 4.2 (MA PMP Pharmacy Guide) and this MA PMP Pharmacy FAQ document. Check the MA PMP website for additional content. The DCP website address is: MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 1 of 10

2 The Board of Registration in Pharmacy website address is: MA PMP staff contact information Q) Can you provide MA PMP staff contact information? A) s can be sent to: Please call the main MA PMP number for questions: For general questions, ask for Adele Audet; For technical questions, ask for Arnold Bilansky. For software or submission of data questions, contact Atlantic Associates, Inc. (AAI). AAI can be reached at (800) Prescription records that must be submitted to the MA PMP 2.1 Dispensed prescriptions to non-residents of Massachusetts Q) When a pharmacy in Massachusetts dispenses a Schedule II V prescription to a nonresident of Massachusetts, does the pharmacy have to submit the prescription information to the MA PMP? A) Yes. Information on all Schedule II V prescriptions dispensed by a pharmacy located in Massachusetts must be submitted to the MA PMP regardless of the location or residence of the patient or the prescriber. 2.2 Registered Massachusetts Health Care Facilities Q) What constitutes a registered health care facility that is required to submit data on Schedule II V prescriptions to the MA PMP? A) A registered health care facility (i.e., a hospital or clinic) must have a Massachusetts Controlled Substances Registration from the DCP. A pharmacy in a registered health care facility that dispenses any Schedule II V controlled substances pursuant to a prescription is required to submit data to the MA PMP. 2.3 Medication orders for inpatients Q) Are hospital or clinic inpatient pharmacies required to submit data if they only fill medication orders for their inpatients? A) Pharmacies in registered health care facilities that dispense to according medication orders that are administered within the facility (i.e., inpatients) are not required to submit the medication order data to the MA PMP. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 2 of 10

3 2.4 Prescriptions for research subjects Q) Does a hospital pharmacy have to report prescriptions from clinical trials? The drug product s NDC number is often not known or it has not been assigned by the FDA. A) No. MDPH is waiving MA PMP reporting requirements for prescriptions dispensed to patients who are research subjects of Institutional Review Board (IRB) approved research protocols. 2.5 Long-term care facility reporting Q) Do prescriptions for residents of long-term care facilities have to be reported to the MA PMP? A) Pharmacies that dispense prescriptions to residents of long-term care facilities must submit reports to the MA PMP. 2.6 Mail order pharmacies Q) Are mail order pharmacies located in Massachusetts required to submit data on prescriptions for Schedule II V drugs shipped to patients in other states? A) Yes. Pharmacies located in Massachusetts are required to report all the prescriptions for Schedule II V drugs they dispense, regardless of a patient s location/residence Q) Are mail order pharmacies located outside Massachusetts required to submit data to the MA PMP when prescriptions for Schedule II V drugs are delivered to patients in Massachusetts? A) Yes. Effective January 1, 2011, MA PMP reporting requirements also apply to any pharmacy located in another state, commonwealth, district or territory that delivers a Schedule II V prescription to a person in Massachusetts. Pharmacies that meet the above criteria must collect and submit data to the MA PMP. This includes, but is not limited to, mail-order pharmacies Q) Are out-of-state mail order pharmacies required to submit ASAP Zero Reports to the MA PMP? A) Yes. Out-of-state pharmacies that deliver prescriptions to persons located in Massachusetts are required to submit ASAP Zero Reports to MA PMP for those weeks when no qualifying Schedule II V prescriptions are dispensed. Out-of-state pharmacies that rarely or never deliver such prescriptions to patients in Massachusetts should contact AAI to request a Zero Reporting Exemption form for an annual exemption from the ASAP Zero Report submissions. The Zero Reporting Exemption does not exempt them from reporting the few prescriptions that they do deliver to Massachusetts patients. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 3 of 10

4 3 Customer identification 3.1 Requiring customer to show identification Q) When a customer presents a written prescription at the pharmacy, will the pharmacist or technician have to determine if the prescription is for a Schedule II V drug product before the person leaves? A) A pharmacy that routinely inspects and records the customer identification when written prescriptions for Schedule II V drugs are presented at the pharmacy, should determine if the prescription is for a Schedule II V drug before the customer leaves. If the pharmacy determines the prescription is for a Schedule II V drug after the customer has left, the pharmacy will have to inspect the identification and enter the data of the customer who receives the prescription Q) If a prescription is presented at the pharmacy by one individual but another individual takes possession of the filled prescription, does the pharmacy have to report the customer identification of both individuals? A) No. Information is required for one or the other, not both Q) According to the MA PMP Pharmacy Guide, Customer ID information is not required to be reported on refills. Does this exception apply for the following circumstance: All of the refills have been dispensed on a Schedule III V prescription or the prescription has expired, and the patient obtains a new prescription from the prescriber that continues the drug therapy or treatment? A) No. A new prescription that continues a drug therapy or treatment is a new prescription and not a refill. 3.2 ID Qualifier field Q) When using the MA Registry of Motor Vehicles Identification in the AIR05 [Customer ID] field, what value do we use in the AIR04 [ID Qualifier] field? A) Use 02 for State issued ID. 3.3 Customer ID field Q) If a pharmacy already has an identifier entered for a customer (e.g. Driver s License Number), is it permissible for the pharmacy system to automatically populate the retained ID or must the ID be manually entered for each prescription? A) A previously stored ID should never be automatically entered. The ID information must be specific to the valid ID of the customer and contemporaneous with the presenting or receiving of the prescription. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 4 of 10

5 3.4 Issuing Jurisdiction of Customer ID field Q) Where is there a list of valid country codes to enter into field AIR03 [Issuing Jurisdiction (of Customer ID)]? For example, for a Japanese passport, would we enter JP or JAP? A) The List of Jurisdictions is published as Appendix A of the ASAP 4.2 Implementation Guide. Most of the codes on that list are for United States Postal System, for U.S. states, for Canadian provinces, and for current or previous U.S. territories or protectorates. For a federally issued ID, use US. Very few foreign countries are listed. For any jurisdiction not explicitly stated in the List of Jurisdictions use the code 99 for Other. Please note that the code for Other in this field has changed to 99 in ASAP 4.2 in order to be consistent with the code for Other used elsewhere in ASAP 4.2. ASAP has granted permission to freely distribute the copyrighted List of Jurisdictions. 3.5 Deliveries Q) Previously there were customer ID fields for different delivery situations (patient residence, hospice facilities, long-term care facilities, other DPH licensed health care facilities, assisted living residences, boarding schools, prisons, jails, community programs, etc.). What fields are used for deliveries now? A) All of the delivery situations listed above have been simplified and are now treated collectively as deliveries. Please see the topic Exceptions to the Customer ID Requirement and the specific Deliveries topic in the MA PMP Pharmacy Guide for details Q) The MA PMP Pharmacy Guide indicates that when utilizing the Delivery exemption to Leave blank fields AIR03 and AIR04. My data entry screen has dropdown choices. How do I leave those blank? A) The software provider needs to configure the data entry screen to permit no code as a choice. For a Leave blank situation, the software provider needs to populate the field in the same manner that a middle name field would be populated when a person has no middle name (i.e., Data Element Separator only with no text). Stated another way, Leave blank, means the software provider should treat the field the same way they would treat a Not Used field. 3.6 Customer ID for hospital outpatients Q) Can a hospital outpatient pharmacy use the hospital issued identification card? A) No. The pharmacy may not substitute the hospital issued identification card for a valid form of identification. For patients/customers without an MA PMP approved ID, the pharmacy will have to follow the procedures described for the waiver in item No. 1 in the MA PMP Pharmacy Guide, under topic heading Exceptions to the Customer ID Requirement (i.e., cust signed rx detail) Q) Often prescriptions are left at the hospital pharmacy by a physician, nurse, or office assistant, or received via pneumatic tube. Could we use the patient s hospital identification number in these instances? A) No, the hospital patient identification number may NOT be used as a substitute for a valid form of identification. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 5 of 10

6 While the pharmacy s routine practice may be to inspect customer ID and enter the information into the computer when the written prescription is presented, the pharmacy is not required to do this for all prescriptions (e.g., for some prescriptions the pharmacy will inspect the customer ID and enter the information when the customer receives the filled prescription). To provide an appropriate level of accountability, it is preferable for the hospital pharmacy to provide ID information regarding the person who receives the filled prescription, rather than a hospital staff member who presents the prescription to the pharmacy. 3.7 Utilizing the cust signed rx waiver when the Customer ID cannot be presented Q) When a customer cannot show an ID, where does the pharmacist document the reason (as required in the regulations) for dispensing a Schedule II V prescription? A) To promote consistency and compliance with regulations, each pharmacy should develop its own internal procedure for documenting, in a readily retrievable format; the reason the pharmacist determined that failure to dispense the controlled substance would result in a serious hardship for the ultimate user or agent of the ultimate user. Examples of where to record the documentation would be on the hard-copy prescription or in the pharmacy software system. In addition, the pharmacy must: Have the customer print his or her name and address and sign his or her name on the reverse side of the prescription. Enter cust signed rx in the Customer ID field rather than leaving the field blank Q) When utilizing cust signed rx waiver, how should other fields requiring customer information be populated? A) Populate the relevant fields as follows: AIR03 [Issuing Jurisdiction (of Customer ID]: Leave blank AIR04 [ID Qualifier (of Customer ID)]: Leave blank. AIR05 [(Customer) ID]: Enter the term cust signed rx. Please be careful to enter cust signed rx exactly, incorrect entries interfere with the ability to retrieve and analyze prescription data. AIR06 [Relationship of the customer to the patient] Enter either 01 when the customer is the patient or 99 when the customer is someone else Q) Does the complete term, cust signed rx need to be populated in the Customer ID field? The Customer ID field for the particular pharmacy system in question is currently 12 characters wide and cust signed rx is 14 characters wide. A) Yes, the exact wording, cust signed rx, is required. In ASAP 4.2 (and all previous ASAP versions) the Customer ID field is required to accommodate up to 20 characters. This width was established because a Customer ID may be issued by any of a large number of jurisdictions including foreign countries. The field must be able to accommodate the widths of all of the possible ID s. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 6 of 10

7 3.7.4 Q) Who is the Massachusetts regulation referring to when it states the ultimate user or agent of ultimate user in the Exceptions to the Customer ID Requirement box of the MA PMP Pharmacy Guide? A) The ultimate user is the individual who is being treated with the Schedule II V controlled substance(s). The agent of the ultimate user is a person who presents the prescription or receives the filled prescription on behalf of the ultimate user. The ultimate user or agent of ultimate user is statutory language (M.G.L. Chapter94C) Q) If the customer only has a passport ID, does the MA PMP have a preference as to whether the pharmacy should enter cust signed rx in the customer ID field or the passport ID? A) Enter the passport ID if it is current and valid. If a customer has any of the MA PMP approved ID s (driver s license, RMV ID, military ID, passport, Permanent Resident Card, or MA Commission for the Blind ID), that ID must be used for data entry. 3.8 Customer ID for Health Safety Net recipients who do not have any of the required forms of ID Q) Can the MassHealth Recipient Identification card number or the Eligibility Verification System (EVS) be inspected by pharmacies and be entered in the Customer ID data fields, especially for non-citizens who obtain prescription drug coverage under the Commonwealth s Health Safety Net Trust fund pursuant to CMR 13.00? A) No. The MassHealth Recipient Identification card is not one of the MA PMP-approved customer ID s. This identification card lacks a photograph, which increases the potential for fraud(e.g., forgery). If the customer cannot show one of the six approved forms of identification, then follow the procedures described for the waiver in item No. 1 in the MA PMP Pharmacy Guide under the topic Exceptions to the Customer ID Requirement concerning when a positive ID cannot be obtained. 4 OTHER FIELDS 4.1 Patient Location Code Q) What are the descriptions and acceptable values used to report PAT21 - Patient Location Code? A) The code values that the MA PMP requires are provided in the ASAP 4.2 Implementation Guide. If the list of codes does not have a code that precisely describes the patient s location, the pharmacist should use professional judgment in determining the closest applicable code to use. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 7 of 10

8 4.2 Method of Payment Q) If a third-party payer pays for some part of a prescription but there is a co-pay paid by the patient, should the code entered in DSP16 [Classification Code for Payment Type] be 01 for Private Pay or 99 for Other? A) Use the code 99 for other. If any amount of the prescription payment is covered by a third party - even when the patient makes a copayment - use the code 99 for other. If the entire amount of the prescription price is paid by the customer or patient, use the code 01 for private pay. If, for some other pharmacy claims purpose, a pharmacy needs to enter another more specific payment type code (besides 01 or 99 ), the MA PMP will not reject that code as long as it is one of the ASAP 4.2 standard DSP16 approved codes. 4.3 Prescriber DEA number for Buprenorphine Q) Should pharmacies submit the DEA X number for buprenorphine prescriptions? A) With respect to prescriptions for buprenorphine drug products prescribed for opioid maintenance therapy, when both the physician s primary DEA number and the DATA 2000 waiver ID ( X ) number appear on the prescription, the MA PMP prefers that the X number be submitted to the MA PMP rather than the physician s primary DEA number. For buprenorphine drug products dispensed for treatment of pain, use the prescriber s primary DEA number. 4.4 Electronic Prescriptions Q) The MA PMP Pharmacy Guide says that the fields DSP18, DSP19, DSP20, DSP21, and DSP12 need to be populated when dispensing an electronically received prescription. When we receive a faxed prescription, we can manually enter DSP12, but we do not receive the information for DSP18, DSP19, DSP20, and DSP21. A) Faxes are not electronic prescriptions. The DEA rules for Electronic Prescriptions for Controlled Substances are at 21 CFR Parts 1300, 1304, 1306, and Data quality and usefulness 5.1 Adding descriptive information into data fields Q) Is it helpful to the patient s nickname in parenthesis to the first name field? A) No. Sorting and searching in the MA PMP database relies on all pharmacies submitting names accurately for the each patient. For constancy across pharmacies, a good rule of thumb for patient name fields, when possible, is to enter the name the same way it appears on a patient s insurance card or drivers license. It is also counter-productive to enter anything in the customer ID field other than the ID number itself. For the Exception cases where cust signed rx or delivery are to be entered into the customer ID field, please try to spell them exactly that way. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 8 of 10

9 A substantial amount of time and resources are expended by the MA PMP on attempting to clean up extraneously entered data, as well as in educating pharmacy staff to avoid adding extra text to any fields. 6 Data Corrections / Resubmissions / Deletions 6.1 Prescriptions not picked up Q) A pharmacy submits data for a prescription that has been prepared but never picked up. The pharmacy returns the medication to stock. How should the pharmacy proceed to reverse or cancel the data submitted to the MA PMP? Should the transaction be re-sent with a negative quantity? A) If the pharmacy has a need to void out any prescriptions submitted to the MA PMP, they should use the DSP01 [Reporting Status] field and enter 02 Void. The other data elements must be entered exactly as initially reported. (i.e., if the metric quantity initially reported as dispensed was 30, in the cancel record also report it as 30). Do NOT use negative numbers. 6.2 Pharmacy prescription corrections Q) After submitting information to the MA PMP, what should a pharmacy do if they find that a prescription record must be changed or corrected? A) Pharmacies submitting changed or corrected data will use the DSP01 [Reporting Status] field and enter 01 Revise or 02 Void. If using the 02 code, also follow the procedure described in above. 6.3 Externally requested corrections Q) Prescribers and dispensers can now retrieve patient information from the MA Online MA PMP. If a discrepancy is discovered in the data for a particular MA Online MA PMP prescription record (for example, the identity of the prescriber or the name of the patient appears to be incorrect) how can a person request correction(s) to the data? A) If the MA PMP is alerted by anyone other than the submitting pharmacy regarding incorrect information, MA PMP staff will contact the pharmacy with a request to verify the information and, if neededto resubmit the prescription record with a correction Q) There have been problems with data submissions because the NDC numbers are not padded properly. How should NDC numbers be submitted? A) NDC numbers are listed on product packages as ten numerals separated by hyphens into three segments. The first segment represents the labeler, the second segment represents the product and the third segment represents the package size. Depending upon the product, the NDC will appear in one of three configurations: 4-4-2, 5-3-2, or In order to standardize an equal width for each segment, the NDC needs to be reported as an 11 character numeric field with no hyphens (i.e., with the hyphens omitted). So a NDC configuration must be reported with a zero padded in front of the first segment; a configuration must be reported with a zero padded in front of the second segment; and a configuration must be reported with the last segment padded in front with a zero. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 9 of 10

10 7 ASAP 4.2 issues Q) Our pharmacy MA PMP software is based upon ASAP 4.1. In calendar year 2014 MA PMP is transitioning to accept the ASAP 4.2 format. What are the main data entry differences pharmacists will find when entering prescription data? A) As indicated earlier in this document, it is difficult to precisely describe the changes that pharmacists (and pharmacy technicians) will see because the software provider may customize the interface such that only user friendly names for field names and code values rather than more cryptic ASAP field names and code values are visible. Most of the new field information is related to electronic prescriptions. Since that data is sent electronically to the pharmacy computer system, the required fields for electronic prescriptions should automatically populate behind the scenes. Please check with the software vendor. (Please be aware that when entering prescription information for an electronic prescription, the DSP12 field with must still be coded to indicate that it is an electronic prescription.) Perhaps the only noticeable difference in data entry will be for the partial fill field, DSP13, which is now coded differently in ASAP 4.2. In ASAP 4.2; a nonpartial fill is 00 ; a first partial fill is 01 ; second partial fill is 02, etc. Please check with the software provider, because there may a difference in how to enter a split-fill as opposed to a partial fill. MA PMP Pharmacy FAQ Last updated::april 8, 2014 Page 10 of 10

FREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION

FREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION FREQUENTLY ASKED QUESTIONS ABOUT ELECTRONIC DATA TRANSMISSION for the Revised: July 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

PRESCRIPTION MONITORING PROGRAM (PMP)

PRESCRIPTION MONITORING PROGRAM (PMP) PRESCRIPTION MONITORING PROGRAM (PMP) DATA REPORTING MANUAL Effective Date: April 1, 2012 Contact Information: (505) 222-9830 larry.loring@state.nm.us 1 P a g e Table of Contents Reporting requirements

More information

LOUISIANA PRESCRIPTION MONITORING PROGRAM

LOUISIANA PRESCRIPTION MONITORING PROGRAM LOUISIANA PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL - VERSION 1.0 Revision History Date Version Description Author 12/13/2013 1.0 Initial version Lena Roe (Otech) 1/28/2014 1.1 Updates Lena

More information

NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP)

NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP) NEW JERSEY PRESCRIPTION MONITORING PROGRAM (NJPMP) DATA COLLECTION MANUAL Effective Date: January 1, 2015 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 NJRxReport@otech.com Fax: 866-282-7076

More information

RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL

RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: October 13, 2014 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 Fax: 866-282-7076 RIRxReport@otech.com

More information

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016 FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: October 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

Massachusetts Department of Public Health Prescription Monitoring Program Pharmacy Discussion Document; February 2016

Massachusetts Department of Public Health Prescription Monitoring Program Pharmacy Discussion Document; February 2016 MA DPH has selected Appriss as the vendor for the new PMP solution. The Appriss solution provides both a new data collection tool (PMP learinghouse) and a new online PMP tool (Massachusetts Prescription

More information

Manual of Instructions

Manual of Instructions NEW YORK STATE DEPARTMENT OF HEALTH OFFICIAL NEW YORK STATE PRESCRIPTION PROGRAM ELECTRONIC DATA TRANSMISSION Manual of Instructions New York State Department of Health Bureau of Narcotic Enforcement 433

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

WellDyneRx Mail Service General Questions and Answers

WellDyneRx Mail Service General Questions and Answers WellDyneRx Mail Service General Questions and Answers I. Location/ Hours of Operation 1. Where is WellDyneRx Mail Pharmacy located? WellDyneRx mail pharmacy has two locations: 1) Centennial, CO, a suburb

More information

LOUISIANA PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL

LOUISIANA PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL LOUISIANA PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: January 1, 2015 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 LABPPMP@otech.com Fax: 866-282-7076 Table

More information

PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R047-15. September 15, 2015

PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R047-15. September 15, 2015 PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY LCB File No. R047-15 September 15, 2015 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY:

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is

More information

How To Check If A Prescription Is Filled In An Azarama

How To Check If A Prescription Is Filled In An Azarama ARIZONA CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: January 1, 2015 Optimum Technology, Inc. 100 E. Campus View Blvd, Suite 380, Columbus, OH 43235 Contact

More information

Table of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4

Table of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4 Table of Contents User Request for Access... 3 User Login... 3 Upload a Data File... 4 Add Patient Records Direct Dispenser Users... 5 Pharmacy... 8 Search for Patient Records... 10 Search for Error Records...

More information

ACTION ITEM COMPLETED TAB 44

ACTION ITEM COMPLETED TAB 44 H.B. 1 H.B. 751 Provisions of the H.B. 1 Appropriations Act The base appropriation for TSBP for FY2016-2017 is approximately $234,000 more than the base appropriation the previous biennium. The majority

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

Table of Contents. 2 P a g e

Table of Contents. 2 P a g e Table of Contents Introduction... 3 Important Contact Information... 3 Pharmacy Rights... 3 Claims Adjudication... 3 Reversals... 4 Required Data Fields... 4 Identification cards... 4 Required Identification

More information

Frequently Asked Questions regarding Nurse Practitioners and Protocol Agreements

Frequently Asked Questions regarding Nurse Practitioners and Protocol Agreements Frequently Asked Questions regarding Nurse Practitioners and Protocol Agreements Who needs to submit a Nurse Protocol Agreement to the Georgia Medical Board? If an APRN has been delegated prescriptive

More information

Pharmacy Operating Guidelines & Information

Pharmacy Operating Guidelines & Information Pharmacy Operating Guidelines & Information RxAMERICA PHARMACY BENEFIT MANAGEMENT Pharmacy Operating Guidelines & Information Table of Contents I. Quick Reference List...3 C. D. E. Important Phone Numbers...

More information

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel: Commonwealth of Massachusetts Department of Public Health, Office of Prescription Monitoring and Drug Control 99 Chauncy Street, Boston, MA 02111 Tel: 617-753-7310 Email: mapmp.dph@state.ma.us MA ONLINE

More information

Medicare Part D Plan Finder instructions

Medicare Part D Plan Finder instructions Medicare Part D Plan Finder instructions You can use these instructions to help you find the lowest cost Part D plans (both stand alone and Advantage plans) for the prescription drugs that you take. You

More information

Dispenser s Implementation Guide

Dispenser s Implementation Guide Alabama Department of Public Health Prescription Drug Monitoring Program October 2014 This document is formatted for duplex printing. This page intentionally left blank. Copyright 2009-2014 Health Information

More information

Medicare Part D Plan Finder instructions

Medicare Part D Plan Finder instructions Medicare Part D Plan Finder instructions These instructions may help you find the lowest cost Part D coverage (in both stand alone and Advantage plans). You may need these detailed instructions to get

More information

Pharmacy Program Pre-Test

Pharmacy Program Pre-Test Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group

More information

NH Laws / Rules Regarding Limited Retail Drug Distributors

NH Laws / Rules Regarding Limited Retail Drug Distributors NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant

More information

SECTION.1800 - PRESCRIPTIONS

SECTION.1800 - PRESCRIPTIONS SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or

More information

Co-Pay Assistance Program for CUBICIN (daptomycin for injection) for Intravenous Use Enrollment Form

Co-Pay Assistance Program for CUBICIN (daptomycin for injection) for Intravenous Use Enrollment Form 1. PATIENT INFORMATION Name Gender: o Male o Female Date of Birth: / / Address City State ZIP Email Home Phone Cell Phone Work Phone Alternate Contact Person (Optional) Alternate Phone Number (Optional)

More information

VERMONT PRESCRIPTION MONITORING SYSTEM DATA COLLECTION MANUAL

VERMONT PRESCRIPTION MONITORING SYSTEM DATA COLLECTION MANUAL VERMONT PRESCRIPTION MONITORING SYSTEM DATA COLLECTION MANUAL Effective Date: August 31, 2015 Appriss, Inc. 400 West Wilson Bridge Road, Suite 305; Columbus, OH 43085 Contact Information Phone: 888-461-8628

More information

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as

More information

DC DEPARTMENT OF HEALTH Pharmaceutical Procurement and Distribution Pharmaceutical Warehouse. DC Health Care Safety Net ALLIANCE PROGRAM

DC DEPARTMENT OF HEALTH Pharmaceutical Procurement and Distribution Pharmaceutical Warehouse. DC Health Care Safety Net ALLIANCE PROGRAM DC DEPARTMENT OF HEALTH Pharmaceutical Warehouse DC Health Care Safety Net ALLIANCE PROGRAM OPERATIONAL PROTOCOLS Operational protocols for the DC Health Care Alliance program through the DOH Pharmaceutical

More information

Drug Diversion. Controlled Substance Prescribing and Diversion

Drug Diversion. Controlled Substance Prescribing and Diversion Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation

More information

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity Technical Assistance Guide PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity This project was supported by Grant No. 2011-PM-BX-K001 awarded by the Bureau of Justice Assistance.

More information

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes # scored items 1. Regulations and Pharmacy Duties 35 A. Overview of technician

More information

Maryland Prescription Drug Monitoring Program (PDMP) Hospice Inpatient Waiver Application

Maryland Prescription Drug Monitoring Program (PDMP) Hospice Inpatient Waiver Application 1 Maryland Prescription Drug Monitoring Program (PDMP) Hospice Inpatient Waiver Application Background Health-General Article, Section 21-2A-03(f), Annotated Code of Maryland, allows pharmacies to be granted

More information

MAL 565 (Change to Coverage of Prescription Drugs and Certain Supplies) SUBJECT: Changes to Coverage of Prescription Drugs and Certain Supplies

MAL 565 (Change to Coverage of Prescription Drugs and Certain Supplies) SUBJECT: Changes to Coverage of Prescription Drugs and Certain Supplies Medical Assistance Letters MAL 565 (Change to Coverage of Prescription Drugs and Certain Supplies) Medical Assistance Letter (MAL) 565 January 26, 2010 TO: All Eligible Pharmacy Providers Directors, County

More information

PHARMACY MANUAL. WHP Health Initiatives, Inc. 2275 Half Day Road, Suite 250 Bannockburn, IL 60015

PHARMACY MANUAL. WHP Health Initiatives, Inc. 2275 Half Day Road, Suite 250 Bannockburn, IL 60015 PHARMACY MANUAL WHP Health Initiatives, Inc. 2275 Half Day Road, Suite 250 Bannockburn, IL 60015 Welcome WHP Health Initiatives, Inc. ( WHI ) is pleased to welcome you to our network of participating pharmacies.

More information

Alaska Prescription Drug Monitoring Program

Alaska Prescription Drug Monitoring Program Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this

More information

Anthem s Prescription Drug Plan

Anthem s Prescription Drug Plan This information applies only to clients migrating from legacy WellPoint NextRx to Express Scripts, and does not apply to new clients implementing the Anthem prescription drug plan in 2010. Anthem s Prescription

More information

Investigational Drugs: Investigational Drugs and Biologics

Investigational Drugs: Investigational Drugs and Biologics : I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place

More information

State Prescription Monitoring Program (SPMP) Patch PSO*7*408. Release Notes

State Prescription Monitoring Program (SPMP) Patch PSO*7*408. Release Notes State Prescription Monitoring Program (SPMP) Patch PSO*7*408 August 2014 Department of Veterans Affairs Product Development Table of Contents 1. Introduction... 1 1.1 Purpose... 1 1.2 Menu with Options...

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 8.00: PHARMACY INTERNS AND TECHNICIANS Section 8.01: Pharmacy Interns 8.02: Pharmacy Technicians 8.03: Pharmacy Technician Trainees 8.04: Certified Pharmacy Technicians 8.05: Requirements for the

More information

Idaho Prescription Monitoring Program

Idaho Prescription Monitoring Program Data Submission Dispenser Guide Idaho Prescription Monitoring Program evised ovember 2014 Table of Contents 1. Data Collection and Tracking...4 eporting equirements... 4 2. Data Submission...4 About This

More information

4. Program Regulations

4. Program Regulations Table of Contents iv 406.401: Introduction... 4-1 406.402: Definitions... 4-1 406.403: Eligible Members... 4-4 406.404: Provider Eligibility... 4-4 406.405: Drugs and Medical Supplies Provided Outside

More information

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Legislative changes PDMP program changes 503B outsourcing facilities Rules changes Ph800 review Ph300 Ph400 Ph700 Current issues

More information

211 CMR 134.00: SAFE DRIVER INSURANCE PLAN. Section

211 CMR 134.00: SAFE DRIVER INSURANCE PLAN. Section 1 211 CMR 134.00: SAFE DRIVER INSURANCE PLAN Section 134.01: Authority 134.02: Purpose, Scope and Responsibility 134.03: Definitions 134.04: Relevant Vehicles, Policies, Accidents, Traffic Law Violations

More information

Administrative Procedures for the Safe Driver Insurance Plan (SDIP)

Administrative Procedures for the Safe Driver Insurance Plan (SDIP) Administrative Procedures for the Safe Driver Insurance Plan (SDIP) Prepared By: Merit Rating Board Date Updated: April 17, 2014 Table of Contents Chapter 1 INTRODUCTION... 1 Authority... 2 Merit Rating

More information

INSTRUCTIONS FOR USE: OA-RX

INSTRUCTIONS FOR USE: OA-RX P a g e 1 INSTRUCTIONS FOR USE: OA-RX Welcome to Office Ally s Electronic Prescription module, called OA-Rx. This web-based program has been designed to integrate into Office Ally s Practice Mate and EHR

More information

Humana Pharmacy Solutions Audit Guide

Humana Pharmacy Solutions Audit Guide Humana Pharmacy Solutions Guide Introduction 1.0 Overview 2.0 Types/Description of Process 2.1 Telephone 2.2 Desktop 2.3 Onsite 3.0 Appeals 4.0 Adjustments 5.0 Documentation Requirements 5.1 For an E-Script

More information

RMIP Prescription Plan FAQ's

RMIP Prescription Plan FAQ's RMIP Prescription Plan FAQ's A new U.S. Pharmacy Benefit Manager has been selected for January 1, 2015 - CVS/caremark. 1) Why is the RMIP changing to CVS/caremark? The Express Scripts contract ends on

More information

Wisconsin Department of Safety and Professional Services

Wisconsin Department of Safety and Professional Services Mail To: P.O. Box 8935 Madison, WI 53708-8935 1400 E. Washington Avenue Madison, WI 53703 FAX #: (608) 261-7083 Phone #: (608) 266-2112 E-Mail: web@dsps.wi.gov Website: http://dsps.wi.gov PHARMACY EXAMINING

More information

North Carolina Medicaid Special Bulletin

North Carolina Medicaid Special Bulletin North Carolina Medicaid Special Bulletin An Information Service of the Division of Medical Assistance Please visit our Web site at www.ncdhhs.gov/dma July 2007 ATTENTION: All Providers Notice of Change

More information

Empire s Prescription Drug Plan

Empire s Prescription Drug Plan Empire s Prescription Drug Plan Empire s prescription drug program is about more than processing claims and making prescriptions available. It s about looking at each person as an individual. Because we

More information

DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS

DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS Title 17 District of Columbia Municipal Regulations DISTRICT OF COLUMBIA MUNICIPAL REGULATIONS FOR PHARMACY TECHNICIANS Effective CHAPTER 99 PHARMACY TECHNICIANS Secs. 9900 General Provisions 9901 Term

More information

SUBMITTER S GUIDE TO ELECTRONIC DATA TRANSMISSION

SUBMITTER S GUIDE TO ELECTRONIC DATA TRANSMISSION SUBMITTER S GUIDE TO ELECTRONIC DATA TRANSMISSION for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and

More information

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11 Effective Date: 09/12/06, 08/02/10, 3/2/11 Title: 1.0 OBJECTIVE: 1.1 This SOP describes the methods and policies for: Handling investigational drug Dispensing investigational drug 1.2. This procedure applies

More information

- 1 - First Time Pharmacy Managers (Revised 02/02/2011)

- 1 - First Time Pharmacy Managers (Revised 02/02/2011) State of Connecticut Department of Consumer Protection Commission of Pharmacy 165 Capitol Avenue, Room 147 Hartford, CT 06106 - Telephone: 860-713-6070 ALL FIRST-TIME PHARMACY MANAGERS ARE REQUIRED TO

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE April 8, 2011 EFFECTIVE DATE April 8, 2011 MEDICAL ASSISTANCE BULLETIN NUMBER 03-11-01, 09-11-02, 14-11-01, 18-11-01 24-11-03, 27-11-02, 31-11-02, 33-11-02 SUBJECT Electronic Prescribing Internet-based

More information

PMP AWAR X E. User Support Manual V 1.2

PMP AWAR X E. User Support Manual V 1.2 PMP AWAR X E User Support Manual V 1.2 04/09/2014 1 Contents 1 What Is a Requestor?... 3 2 Registration... 3 2.1 Registration Process... 3 2.2 Registering as a Delegate... 7 2.3 Email Verification... 11

More information

PHARMACY. billing module

PHARMACY. billing module PHARMACY billing module Pharmacy Billing Module Coding...2 Basic Rules...2 Before You Begin...2 Reimbursement and Copayment...3 Point of Sale Billing...4 Billing for Split Prescriptions...5 Billing of

More information

REGULATION 3 PHARMACY TECHNICIANS

REGULATION 3 PHARMACY TECHNICIANS REGULATION 3 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS (a) Pharmacy technician means those individuals, exclusive of pharmacy interns, who assist

More information

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

Frequently Asked Questions For Middlesex Community College Students 2013-2014 Student Health Insurance Plan

Frequently Asked Questions For Middlesex Community College Students 2013-2014 Student Health Insurance Plan Frequently Asked Questions For Middlesex Community College Students 2013-2014 Student Health Insurance Plan Table of Contents Important Contact Information... 2 I have questions about what is covered,

More information

DEPARTMENT OF HEALTH NOTICE OF PROPOSED RULEMAKING

DEPARTMENT OF HEALTH NOTICE OF PROPOSED RULEMAKING DEPARTMENT OF HEALTH NOTICE OF PROPOSED RULEMAKING The Director of the Department of Health ( Department ), pursuant to the District of Columbia Health Occupations Revision Act of 1985, effective March

More information

Washington. Contact Information. Email: Statistics. Technological Capabilities

Washington. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington

More information

Health and Dental Insurance Coverage

Health and Dental Insurance Coverage Application for Health and Dental Insurance Coverage Who can use this application? Apply faster online. Use this application for yourself and anyone in your household who needs health or dental insurance

More information

UNIVERSITY OF VICTORIA RETIREES ASSOCIATION

UNIVERSITY OF VICTORIA RETIREES ASSOCIATION RTAM PREMIER TRAVEL PLAN UNIVERSITY OF VICTORIA RETIREES ASSOCIATION VOLUNTARY RETIREE BENEFIT PLAN FREQUENTLY ASKED QUESTIONS Dear UVRA Members: We know that your benefit coverage is important to you.

More information

Medicaid Tamper-Resistant Prescription Requirements FAQs for Pharmacists

Medicaid Tamper-Resistant Prescription Requirements FAQs for Pharmacists Medicaid Tamper-Resistant Prescription Requirements FAQs for Pharmacists On April 1, 2008, all hand-written or computer-generated/printed Medicaid prescriptions were required to have at least one approved

More information

130 CMR: DIVISION OF MEDICAL ASSISTANCE. 130 CMR 416.000: HEARING INSTRUMENT SPECIALIST SERVICES Section

130 CMR: DIVISION OF MEDICAL ASSISTANCE. 130 CMR 416.000: HEARING INSTRUMENT SPECIALIST SERVICES Section 130 CMR 416.000: HEARING INSTRUMENT SPECIALIST SERVICES Section 416.401: 416.402: 416.403: 416.404: 416.405: 416.406: 416.407: 416.408: 416.409: 416.410: 416.414: 416.415: 416.416: 416.417: 416.418: 416.419:

More information

Massachusetts. Contact Information. Statistics. Technological Capabilities

Massachusetts. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted

More information

Contracting and Clean Claims: Billing Techniques for Success!

Contracting and Clean Claims: Billing Techniques for Success! Contracting and Clean Claims: Billing Techniques for Success! Top 5 Things to Know for CE: Make sure your BADGE IS SCANNED each time you enter a session, to record your attendance. Carry the Evaluation

More information

NOTICES OF PROPOSED RULEMAKING

NOTICES OF PROPOSED RULEMAKING NOTICES OF PROPOSED RULEMAKING Unless exempted by A.R.S. 41-1005, each agency shall begin the rulemaking process by first submitting to the Secretary of State s Office a Notice of Rulemaking Docket Opening

More information

ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS

ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS 610-X-5-.01 610-X-5-.02 610-X-5-.03 610-X-5-.04 610-X-5-.05 610-X-5-.06 610-X-5-.07

More information

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1

APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 AUGUST 2015 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 AUGUST 2015 APPENDIX B: VENDOR DRUG PROGRAM Table of Contents

More information

Pursuant to the authority vested in the Commissioner of Health by Article 33 of the

Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Electronic Prescriptions and Records for Hypodermic Needles and Hypodermic Syringes Effective date: 10/9/13 Pursuant to the authority vested in the Commissioner of Health by Article 33 of the Public Health

More information

REQUEST FOR INDEPENDENT EXTERNAL REVIEW OF A HEALTH INSURANCE GRIEVANCE THROUGH THE OFFICE OF PATIENT PROTECTION

REQUEST FOR INDEPENDENT EXTERNAL REVIEW OF A HEALTH INSURANCE GRIEVANCE THROUGH THE OFFICE OF PATIENT PROTECTION The Commonwealth of Massachusetts Health Policy Commission Office of Patient Protection 50 Milk Street, 8 th Floor Boston, MA 02109 (800)436-7757 (phone) (617)624-5046 (fax) REQUEST FOR INDEPENDENT EXTERNAL

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

2014-15 EMPLOYEE BENEFITS GUIDE

2014-15 EMPLOYEE BENEFITS GUIDE 2014-15 EMPLOYEE BENEFITS GUIDE ELIGIBILITY All People 2.0 employees are eligible to enroll in The American Worker program within 30 days of your first pay check. People 2.0 offers a variety of affordable

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

03 PHARMACY TECHNICIANS

03 PHARMACY TECHNICIANS 03 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS: A. PHARMACY TECHNICIAN: This term refers to those individuals identified as Pharmacist Assistants

More information

Connecticut Department of Social Services Medical Assistance Program Provider Bulletin. PB 2008-35 June 2008

Connecticut Department of Social Services Medical Assistance Program Provider Bulletin. PB 2008-35 June 2008 Connecticut Department of Social Services Medical Assistance Program Provider Bulletin PB 2008-35 June 2008 TO: Hospital Providers SUBJECT: *NEW* National Drug Codes (NDC) Required for Outpatient Hospital

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

OLD AGE PENSION HEALTH CARE PROGRAM 8.940 8.941 8.940 OLD AGE PENSION HEALTH CARE PROGRAM AND OLD AGE PENSION HEALTH CARE SUPPLEMENTAL PROGRAM

OLD AGE PENSION HEALTH CARE PROGRAM 8.940 8.941 8.940 OLD AGE PENSION HEALTH CARE PROGRAM AND OLD AGE PENSION HEALTH CARE SUPPLEMENTAL PROGRAM 8.940 8.941 8.940 OLD AGE PENSION HEALTH CARE PROGRAM AND OLD AGE PENSION HEALTH CARE SUPPLEMENTAL PROGRAM 8.941 EXTENT AND LIMITATIONS OF MEDICAL CARE 8.941.1 GENERAL DESCRIPTION - OLD AGE PENSION HEALTH

More information

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations North Carolina Board of Pharmacy Controlled Substance Pocketcard A brief summary of pertinent rules and regulations impacting the practice of pharmacy ~ Controlled II Substance Controlled II Substance

More information

16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain

16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain 16.19.10.11 PUBLIC HEALTH CLINICS: A. CLINIC LICENSURE: (1) All clinics where dangerous drugs are administered, distributed or dispensed shall obtain a limited drug permit as described in Section 61-11-14

More information

Best Practice Recommendation for

Best Practice Recommendation for Best Practice Recommendation for Exchanging & Processing about Pharmacy Benefit Management Version 091714a Issue Date Version Explanation Table of Contents Improvement Opportunity:... 1 Summary of Recommendation:...

More information

2016 Medicare Part D Transition Policy

2016 Medicare Part D Transition Policy Regulation/ Requirements Purpose Scope Policy 2016 Medicare Part D Transition Policy 42 CFR 423.120(b)(3) 42 CFR 423.154(a)(1)(i) 42 CFR 423.578(b) Medicare Prescription Drug Benefit Manual, Chapter 6,

More information

invasion of personal privacy

invasion of personal privacy identifying data deleted to prevent clearly unwarranted invasion of personal privacy U.S. Department of Homeland Security 20 Massachusetts Ave. NW, Rm. 3000 Washington, DC 20529 U. S. Citizenship and Immigration

More information

Query and Reports Tutorial. Minnesota Board of Pharmacy Prescription Monitoring Program

Query and Reports Tutorial. Minnesota Board of Pharmacy Prescription Monitoring Program Minnesota Board of Pharmacy Prescription Monitoring Program August 2015 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 RxSentry Update... 1 2 Accessing RxSentry... 3 Request an Account...

More information

Chase QuickPay SM FAQs

Chase QuickPay SM FAQs Chase QuickPay SM FAQs Using QuickPay How does Chase QuickPay work? 1. You set up a payment 2. Your recipient receives a message 3. Your recipient signs up (if new to Chase QuickPay) 4. Your recipient

More information

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy

More information

956 CMR COMMONWEALTH HEALTH INSURANCE CONNECTOR AUTHORITY 956 CMR 8.00: STUDENT HEALTH INSURANCE PROGRAM

956 CMR COMMONWEALTH HEALTH INSURANCE CONNECTOR AUTHORITY 956 CMR 8.00: STUDENT HEALTH INSURANCE PROGRAM Section 8.01: General Provisions 8.02: Definitions 8.03: Mandatory Health Insurance Coverage 8.04: Student Health Insurance Program Requirements 8.05: Waiver of Participation due to Comparable Coverage

More information

Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules

Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules D. E. A. Rules 21 C.F.R. 1300 Everything that you need to know but were afraid to ask DEA Rules - Objectives The student will be able to discuss the manner in which the DEA regulates the distribution of

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

E-Prescribing FAQ s for Independent Pharmacies Table of Contents

E-Prescribing FAQ s for Independent Pharmacies Table of Contents Table of Contents How do I work with my software vendor to enable my pharmacy for e-prescribing via the Surescripts network?...2 Why must I report issues directly through my software vendor and not Surescripts?...2

More information

Data Layouts and Formats

Data Layouts and Formats Data Layouts and Formats Pharmacy, Dental, and Provider Files March 13, 2008 INSTITUTE FOR CHILD HEALTH POLICY 1 ENCOUNTERS SUBMISSION GUIDELINES 03/13//2008 Table of Contents 1. INTRODUCTION 3 2. GENERAL

More information

4. PROGRAM REQUIREMENTS

4. PROGRAM REQUIREMENTS TABLE OF CONTENTS iv 4. PROGRAM REQUIREMENTS 413.401: Introduction... 4-1 413.402: Definitions... 4-1 413.403: Eligible Members... 4-3 413.404: Provider Eligibility... 4-3 413.405: Services Provided by

More information